The DOI matches its Crossref record; 60 of the 61 references it cites were found in a registry or an index.
Cerebrovascular pathology in Down syndrome and Alzheimer disease
Open accessAbstract
People with Down syndrome (DS) are at high risk for developing Alzheimer disease (AD) with age. Typically, by age 40 years, most people with DS have sufficient neuropathology for an AD diagnosis. Interestingly, atherosclerosis and hypertension are atypical in DS with age, suggesting the lack of these vascular risk factors may be associated with reduced cerebrovascular pathology. However, because the extra copy of APP leads to increased beta-amyloid peptide (Aβ) accumulation in DS, we hypothesized that there would be more extensive and widespread cerebral amyloid angiopathy (CAA) with age in DS relative to sporadic AD. To test this hypothesis CAA, atherosclerosis and arteriolosclerosis were used as measures of cerebrovascular pathology and compared in post mortem tissue from individuals with DS (n = 32), sporadic AD (n = 80) and controls (n = 37). CAA was observed with significantly higher frequencies in brains of individuals with DS compared to sporadic AD and controls. Atherosclerosis and arteriolosclerosis were rare in the cases with DS. CAA in DS may be a target for future interventional clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“People with DSAD have a significant burden of cerebral amyloid angiopathy (CAA), with more severe CAA found than in sporadic AD [25, 40].”
From Apolipoprotein E abundance is elevated in the brains of individuals with Down syndrome–Alzheimer’s disease (2025) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Agresti, A. (2002) · Wiley Series in Probability and Statistics · doi:10.1002/0471249688 · Cited by 6,746
Hyman, B. T., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Carrillo, M. C., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., et al. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.10.007 · Cited by 3,092
(2001) · The Lancet · doi:10.1016/s0140-6736(00)03589-3 · Cited by 1,338
Cerebral amyloid angiopathy. A critical review.
Vinters, H. V. (1987) · Stroke · doi:10.1161/01.str.18.2.311 · Cited by 1,070
Cerebral amyloid angiopathy in the elderly
Viswanathan, A., & Greenberg, S. M. (2011) · Annals of Neurology · doi:10.1002/ana.22516 · Cited by 643
Charidimou, A., Gang, Q., & Werring, D. J. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301308 · Cited by 611
Ellis, R. J., Olichney, J. M., Thal, L. J., Mirra, S. S., Morris, J. C., Beekly, D., & Heyman, A. (1996) · Neurology · doi:10.1212/wnl.46.6.1592 · Cited by 561
A Prospective Study of Alzheimer Disease in Down Syndrome
Lai, F., & Williams, R. S. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520440031017 · Cited by 561
Alzheimer neuropathologic alterations in aged cognitively normal subjects
Davis, D. G., Schmitt, F. A., Wekstein, D. R., & Markesbery, W. R. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199904000-00008 · Cited by 516 · cited 1×
“9 years at autopsy) has been reported as high as 62% [17].”
BackgroundSelf-citation
Research works printed but not linked: 1
- R_Core_Team (2016) A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna
Cited by
Sorted by citations
Dementia in Down syndrome: unique insights for Alzheimer disease research
Lott, I. T., & Head, E. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-018-0132-6 · Cited by 383
Self-citationAlzheimer's disease associated with Down syndrome: a genetic form of dementia
Fortea, J., Zaman, S. H., Hartley, S., Rafii, M. S., Head, E., & Carmona-Iragui, M. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00245-3 · Cited by 357
Self-citationChen, X., & Mobley, W. C. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00659 · Cited by 302
Davidson, Y. S., Robinson, A., Prasher, V. P., & Mann, D. M. A. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0559-4 · Cited by 146
Evolution of neuroinflammation across the lifespan of individuals with Down syndrome
Flores-Aguilar, L., Iulita, M. F., Kovecses, O., Torres, M. D., Levi, S. M., Zhang, Y., Askenazi, M., Wisniewski, T., Busciglio, J., & Cuello, A. C. (2020) · Brain · doi:10.1093/brain/awaa326 · Cited by 138
Further understanding the connection between Alzheimer's disease and Down syndrome
Snyder, H. M., Bain, L. J., Brickman, A. M., Carrillo, M. C., Esbensen, A. J., Espinosa, J. M., Fernandez, F., Fortea, J., Hartley, S. L., Head, E., et al. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12112 · Cited by 105
Self-citationOpportunities, barriers, and recommendations in Down syndrome research
Hendrix, J. A., Amon, A., Abbeduto, L., Agiovlasitis, S., Alsaied, T., Anderson, H. A., Bain, L. J., Baumer, N., Bhattacharyya, A., Bogunovic, D., et al. (2021) · Translational Science of Rare Diseases · doi:10.3233/trd-200090 · Cited by 117
Self-citationBaksh, R. A., Pape, S. E., Chan, L. F., Aslam, A., Gulliford, M. C., & Strydom, A. (2022) · The Lancet Public Health · doi:10.1016/s2468-2667(23)00057-9 · Cited by 104
Alzheimer‐Related Cerebrovascular Disease in Down Syndrome
Lao, P. J., Gutierrez, J., Keator, D. B., Rizvi, B. M., Banerjee, A., Igwe, K. C., Laing, K. K., Sathishkumar, M. T., Moni, F., Andrews, H., et al. (2020) · Annals of Neurology · doi:10.1002/ana.25905 · Cited by 76
Self-citationMann, D. M. A., Davidson, Y. S., Robinson, A. C., Allen, N., Hashimoto, T., Richardson, A., Jones, M., Snowden, J. S., Pendleton, N., Potier, M.-C., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1866-3 · Cited by 73
Martini, A. C., Helman, A. M., McCarty, K. L., Lott, I. T., Doran, E., Schmitt, F. A., & Head, E. (2020) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1002/dad2.12113 · Cited by 66
Self-citationCarmona‐Iragui, M., Videla, L., Lleó, A., & Fortea, J. (2019) · Developmental Neurobiology · doi:10.1002/dneu.22709 · Cited by 68
A review of the mechanisms underlying selected comorbidities in Alzheimer’s disease
Maciejewska, K., Czarnecka, K., & Szymański, P. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00293-5 · Cited by 64
Impact of increased APP gene dose in Down syndrome and the Dp16 mouse model
Sawa, M., Overk, C., Becker, A., Derse, D., Albay, R., Weldy, K., Salehi, A., Beach, T. G., Doran, E., Head, E., et al. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12463 · Cited by 54
Self-citationHelman, A. M., Siever, M., McCarty, K. L., Lott, I. T., Doran, E. W., Abner, E. L., Schmitt, F. A., & Head, E. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180589 · Cited by 49
Self-citationNeuropathological correlates of amyloid PET imaging in Down syndrome
Abrahamson, E. E., Head, E., Lott, I. T., Handen, B. L., Mufson, E. J., Christian, B. T., Klunk, W. E., & Ikonomović, M. D. (2019) · Developmental Neurobiology · doi:10.1002/dneu.22713 · Cited by 46
Self-citationRujeedawa, T., Félez, E. C., Clare, I. C. H., Fortea, J., Strydom, A., Rebillat, A., Coppus, A. M. W., Levin, J., & Zaman, S. H. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10194582 · Cited by 43
Down syndrome and Alzheimer's disease: insights into biomarkers, clinical symptoms, and pathology
Rafii, M. S., Schlachetzki, Z., Barroeta, I., Head, E., Fortea, J., & Ances, B. M. (2025) · The Lancet Neurology · doi:10.1016/s1474-4422(25)00237-6 · Cited by 44
Self-citationThe vexing complexity of the amyloidogenic pathway
Castro, M., Hadziselimovic, A., & Sanders, C. R. (2019) · Protein Science · doi:10.1002/pro.3606 · Cited by 40
Węgiel, J., Flory, M. J., Kuchna, I., Nowicki, K., Wegiel, J., Ma, S. Y., Zhong, N., Wierzba‐Bobrowicz, T., de Leon, M., Lai, F., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01300-9 · Cited by 35
Cerebrovascular disease emerges with age and Alzheimer’s disease in adults with Down syndrome
Lao, P. J., Edwards, N., Aguilar, L. F., Alshikho, M. J., Rizvi, B. M., Tudorascu, D., Rosas, H. D., Yassa, M. A., Christian, B., Mapstone, M. E., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-61962-y · Cited by 30
Self-citationJCS/JCC/JSPCCS 2024 Guideline on Genetic Testing and Counseling in Cardiovascular Disease
Imai, Y., Kusano, K., Aiba, T., Ako, J., Asano, Y., Harada‐Shiba, M., Kataoka, M., Kosho, T., Kubo, T., Matsumura, T., et al. (2024) · Circulation Journal · doi:10.1253/circj.cj-23-0926 · Cited by 34
Martini, A. C., Gross, T. J., Head, E., & Mapstone, M. E. (2022) · Neuron · doi:10.1016/j.neuron.2022.04.001 · Cited by 26
Self-citationLecanemab and Vascular-Amyloid Deposition in Brains of People With Down Syndrome
Liu, L., Saba, A., Pascual, J. R., Miller, M. B., Hennessey, E. L., Lott, I. T., Brickman, A. M., Wilcock, D. M., Harp, J. P., Schmitt, F. A., et al. (2024) · JAMA Neurology · doi:10.1001/jamaneurol.2024.2579 · Cited by 30
Self-citationAlzheimer’s Disease in Down Syndrome: Progress in the Design and Conduct of Drug Prevention Trials
Rafii, M. S. (2020) · CNS Drugs · doi:10.1007/s40263-020-00740-6 · Cited by 26
Astroglial and microglial pathology in Down syndrome: Focus on Alzheimer's disease
Garcı́a, O., & Aguilar, L. F. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.987212 · Cited by 25
Cryo-EM structures reveal tau filaments from Down syndrome adopt Alzheimer’s disease fold
Ghosh, U., Tse, E., Yang, H., Shi, M., Caro, C. D., Wang, F., Merz, G. E., Prusiner, S. B., Southworth, D. R., & Condello, C. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01806-y · Cited by 27
Rodent Modeling of Alzheimer's Disease in Down Syndrome: In vivo and ex vivo Approaches
Farrell, C., Mumford, P., & Wiseman, F. K. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.909669 · Cited by 22
Hetman, M., & Barg, E. (2022) · Biomedicines · doi:10.3390/biomedicines10123219 · Cited by 21
Exploring the role of sex differences in Alzheimer's disease pathogenesis in Down syndrome
Andrews, E. J., Martini, A. C., & Head, E. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.954999 · Cited by 21
Self-citationHead, E., Powell, D. K., & Schmitt, F. A. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00191 · Cited by 20
Self-citationDown syndrome biobank consortium: a perspective
Aldecoa, I., Barroeta, I., Carroll, S. L., Fortea, J., Gilmore, A., Ginsberg, S. D., Guzman, S. J., Hamlett, E. D., Head, E., Perez, S. E., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13692 · Cited by 19
Self-citationSex differences in cardiovascular disease and dysregulation in Down syndrome
Bates, M. L., Vasileva, A., Flores, L. D. M., Pryakhina, Y., Buckman, M. A., Tomasson, M. H., & DeRuisseau, L. R. (2023) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00544.2022 · Cited by 17
Barroeta, I., Videla, L., Carmona‐Iragui, M., Fortea, J., & Rafii, M. S. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70258 · Cited by 18
Cardiovascular Physiology and Pathophysiology in Down Syndrome
Cılhoroz, B., Receno, C. N., Heffernan, K. S., & DeRuisseau, L. R. (2022) · Physiological Research · doi:10.33549/physiolres.934791 · Cited by 17
Ichimata, S., Martínez-Valbuena, I., Lee, S., Li, J., Karakani, A. M., & Kovács, G. G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411596 · Cited by 15
Resistance and resilience to Alzheimer's disease in Down syndrome
Boyle, R. T., Koops, E. A., Ances, B. M., Andrews, E. J., Arenaza‐Urquijo, E. M., Bejanin, A., Brickman, A. M., Buckley, R. F., Clas, G. S., Costello, E., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70151 · Cited by 14
Self-citationMontoliu‐Gaya, L., Bian, S., Dammer, E. B., Alcolea, D. A., Sauer, M., Martá-Ariza, M., Ashton, N. J., Belbin, O., Fuchs, J., Watson, C. M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61054-z · Cited by 18
Sukreet, S., Rafii, M. S., & Rissman, R. A. (2024) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12580 · Cited by 13
Zsadanyi, S. E., Morcillo-Nieto, A. O., Aranha, M. R., Aragón, I., Arriola‐Infante, J. E., Vaqué‐Alcázar, L., Montal, V., Pegueroles, J., Arranz, J., Rodríguez‐Baz, Í., et al. (2024) · Neurology · doi:10.1212/wnl.0000000000209676 · Cited by 15
Watson, L. A., & Meharena, H. S. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1198129 · Cited by 13
Kasri, A., Camporesi, E., Gkanatsiou, E., Boluda, S., Brinkmalm, G., Stimmer, L., Ge, J., Hanrieder, J., Villain, N., Duyckaerts, C. J., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02756-4 · Cited by 16
Untangle the mystery behind DS-associated AD – Is APP the main protagonist?
Elangovan, A., Babu, H. W. S., Iyer, M., Gopalakrishnan, A. V., & Vellingiri, B. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101930 · Cited by 12
The history of Down syndrome–associated Alzheimer's disease; past, present, and future
Maure‐Blesa, L., Carmona‐Iragui, M., Lott, I. T., Head, E., Wısnıewskı, T., Rafii, M. S., Espinosa, J. M., Flórez, J., Mobley, W. C., Holland, A. J., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70158 · Cited by 12
Self-citationGut dysbiosis in Down syndrome: A potentially unexplored culprit for early Alzheimer's disease
Rosas, H. D., Morgan, X. C., Tao, Y., Lai, F., & Mercaldo, N. D. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70330 · Cited by 13
Moni, F., Petersen, M. E., Zhang, F., Lao, P. J., Zimmerman, M. E., Gu, Y., Gutierrez, J., Rizvi, B. M., Laing, K. K., Igwe, K. C., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12627 · Cited by 12
Self-citationPlasma NT1‐tau and Aβ42 correlate with age and cognitive function in two large Down syndrome cohorts
Stern, A. M., Pelt, K. L. V., Liu, L., Anderson, A. K., Ostaszewski, B. L., Mapstone, M. E., O’Bryant, S. E., Petersen, M. E., Christian, B. T., Handen, B. L., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13382 · Cited by 11
Self-citationCardiometabolic risk in young adults with Down syndrome
Manfredo, J. A., Capone, G. T., Yanek, L. R., McCarter, R., Zemel, B. S., Kelly, A. T., & Magge, S. N. (2023) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.63197 · Cited by 10
Farrell, C., Buhidma, Y., Mumford, P., Heywood, W. E., Hällqvist, J., Flores-Aguilar, L., Andrews, E. J., Rahimzadah, N., Taso, O. S., Doran, E., et al. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02889-0 · Cited by 9
“We also found that in DSAD cases, APOE also stains leptomeningeal and parenchymal vessel structures, which may reflect antibody binding to the amyloid found in the vessels due to CAA, which has a high occurrence in DSAD [25, 26, 36, 40], or staining of vascular cells.”
Self-citationBiomarkers in Down syndrome can help us understand Alzheimer's disease
Head, E., & Ances, B. M. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30916-8 · Cited by 9
Self-citationCell type characterization of spatiotemporal gene co-expression modules in Down syndrome brain
Seol, S., Kwon, J., & Kang, H. J. (2022) · iScience · doi:10.1016/j.isci.2022.105884 · Cited by 8
Falgàs, N., Maure‐Blesa, L., Ances, B. M., Aguilar, L. F., Hartley, S. L., Hassenstab, J. J., Iulita, M. F., Janicki, M. P., Koenig, K. A., Lao, P. J., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70309 · Cited by 7
White matter microstructure associations to amyloid burden in adults with Down syndrome
Bazydlo, A., Zammit, M. D., Wu, M., Lao, P. J., Dean, D., Johnson, S. C., Tudorascu, D., Cohen, A. D., Cody, K. A., Ances, B. M., et al. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102908 · Cited by 8
Alzheimer’s drugs, APPlication for Down syndrome?
Sokol, D. K., & Lahiri, D. K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102281 · Cited by 7
Magnetic resonance imaging biomarkers for cognitive decline in Down syndrome
DiProspero, N. D., Kim, S., & Yassa, M. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818845-3.00014-1 · Cited by 11
Calcineurin inhibition may prevent Alzheimer disease in people with Down syndrome
Dohl, J., Treadwell, Z., Norris, C. M., & Head, E. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70034 · Cited by 6
Self-citationDistinct cerebral amyloid angiopathy patterns in adult Down syndrome
Szalárdy, L., Lee, S., Kim, A., & Kovács, G. G. (2025) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2025.123601 · Cited by 6
JCS/JCC/JSPCCS 2024 Guideline on Genetic Testing and Counseling in Cardiovascular Disease
Imai, Y., Kusano, K., Aiba, T., Ako, J., Asano, Y., Harada‐Shiba, M., Kataoka, M., Kosho, T., Kubo, T., Matsumura, T., et al. (2025) · Journal of Cardiology · doi:10.1016/j.jjcc.2024.10.002 · Cited by 6
Pivtoraiko, V. N., Racic, T., Abrahamson, E. E., Villemagne, V. L., Handen, B. L., Lott, I. T., Head, E., & Ikonomović, M. D. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.728739 · Cited by 6
Self-citationDevelopment of Alzheimer’s disease in Down syndrome
García, O. A., Domínguez-de-la-Cruz, E., Luna-Martínez, I. G., Garnett-Carbajal, J. A., & Villegas-Piña, J. A. (2025) · Exploration of neuroscience · doi:10.37349/en.2025.1006104 · Cited by 4
Lemere, C. A., Head, E., & Holtzman, D. M. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2021.1649 · Cited by 5
Self-citationJoseph‐Mathurin, N., & Raji, C. A. (2021) · Springer eBooks · doi:10.1007/978-3-030-82367-2_23 · Cited by 5
Alzheimer’s disease and Down syndrome
Pelt, K. L. V., Head, E., Schmitt, F. A., & Koehl, L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813955-4.00020-9 · Cited by 5
Self-citationWhat Can We Learn About Alzheimer’s Disease from People with Down Syndrome?
Maure‐Blesa, L., Rodríguez‐Baz, Í., Carmona‐Iragui, M., & Fortea, J. (2024) · Current topics in behavioral neurosciences · doi:10.1007/7854_2024_546 · Cited by 5
Age and sex are associated with Alzheimer's disease neuropathology in Down syndrome
Andrews, E. J., Ngo, P. T., Pascual, J. R., Gonzalez, F., Phelan, M. J., Wright, S. T., Harp, J. P., Schmitt, F. A., Lai, F., Lao, P. J., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70408 · Cited by 4
Self-citationCharacterization of neurodegenerative pathologies in adult and pediatric subjects with Down syndrome
Canan, F., Wick, N., Raisanen, J. M., Burns, D. K., Hatanpaa, K. J., Richardson, T. E., White, C. L., & Daoud, E. V. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251362762 · Cited by 4
Leptin levels are associated with body mass index and Alzheimer's disease in Down syndrome
Sordo, L., Du, A. X., Sandadi, V., Dustagheer, F. B., Pascual, J. R., Ngo, P., Hom, C. L., Doran, E. W., & Head, E. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70448 · Cited by 3
Self-citationYanai, K., Ishida, Y., Nishido, H., Miyamoto, S., Yamazaki, K., & Hoya, K. (2019) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2019.01.024 · Cited by 4
Esteban, O., Marcuello, C., Martínez, M., Lavilla, L., Marco, S., & Ascaso, F. J. (2021) · Archivos de la Sociedad Española de Oftalmología (English Edition) · doi:10.1016/j.oftale.2021.01.002 · Cited by 4
Cannavo, C., Tosh, J., Fisher, E., & Wiseman, F. K. (2019) · Progress in brain research · doi:10.1016/bs.pbr.2019.10.004 · Cited by 4
Vertebrate and Invertebrate Animal Models for the Study of Down Syndrome
Granholm, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26168092 · Cited by 6
A pathway linking pulse pressure to dementia in adults with Down syndrome
Rizvi, B. M., Lao, P. J., Sathishkumar, M. T., Taylor, L., Queder, N., McMillan, L. C., Edwards, N. C., Keator, D. B., Doran, E. W., Hom, C. L., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae157 · Cited by 3
Self-citationDown syndrome and a presenilin 2 variant: dual genetic risk of Alzheimer’s disease
Ogg, J. D., Postupna, N. O., Gibbons, L. E., Ariza, J., Xiao, M., Fonseca, L. M., Jayadev, S., Keene, C. D., Bird, T. D., & Latimer, C. S. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02931-1 · Cited by 2
Development of Molecular Neuropathology in Down Syndrome across the Lifespan
Bhattacharyya, A., de la Torre-Ubieta, L., Zhu, Y., Head, E., Swarup, V., & Sousa, A. M. M. (2025) · Journal of Neuroscience · doi:10.1523/jneurosci.1365-25.2025 · Cited by 3
Self-citationNeuroinflammation as a driver of Down syndrome-associated Alzheimer’s disease
Qu, H., Snorradóttir, Á. Ó., Gutierrez-Uzquiza, A., Kao, C., March, M., & Hakonarson, H. H. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.106513 · Cited by 2
Silva, J. A., Liou, J., Parikh, S., Edwards, N. C., Kofler, J., Ikonomovic, M. D., Lai, F., Rosas, H. D., Powell, D. K., Schmitt, F. A., et al. (2026) · npj Dementia · doi:10.1038/s44400-026-00062-2 · Cited by 3
Self-citationThe role of cerebrovascular disease in aging and Alzheimer's disease among people with Down syndrome
Rizvi, B. M., Head, E., & Brickman, A. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818845-3.00012-8 · Cited by 2
Self-citationAlzheimer's Association Update
(2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.06.002 · Cited by 2
Phenotyping Down syndrome: discovery and predictive modelling with electronic medical records
Nguyen, T. Q., Kerley, C. I., Key, A. P. F., Maxwell‐Horn, A., Wells, Q. S., Neul, J. L., Cutting, L. E., & Landman, B. A. (2024) · Journal of Intellectual Disability Research · doi:10.1111/jir.13124 · Cited by 1
Alzheimer's Disease Research Center Down Syndrome Cores: Experience from two sites
Ptomey, L. T., Hom, C. L., Wilkins, H., Doran, E. W., Wright, S. T., Hoang, D., Delehoy, B., Lott, I. T., Perales‐Puchalt, J., Helsel, B. C., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70612 · Cited by 1
Self-citationHayashi, H., Saito, R., Miyashita, A., Ikeuchi, T., Tada, M., Akazawa, K., Onodera, O., Tainaka, K., & Kakita, A. (2026) · Science Advances · doi:10.1126/sciadv.aea7539 · Cited by 1
Aguilar, L. F., Zaikos, T. D., Rivera, I., Wright, S. T., Lou, J., Gawronski, B., Gonzalez, L., Berry, J. V., Rouanet, J. P., Edwards, N. C., et al. (2026) · Acta Neuropathologica · doi:10.1007/s00401-026-03028-z · Cited by 1
Self-citationA plasma protein signature for cerebral amyloid angiopathy
Singh, A., Denkinger, M. N., Leuzy, A., Dieckhoff, K., Liu, J., Marques, T. M., Monuki, E. S., Stark, C., Grill, J. D., Hom, C. L., et al. (2026) · Acta Neuropathologica · doi:10.1007/s00401-026-03030-5 · Cited by 1
Self-citationBiomarkers of Cognitive Decline and Dementia in Down Syndrome
Pais, M. V., Talib, L. L., & Forlenza, O. V. (2023) · Springer eBooks · doi:10.1007/978-3-031-43356-6_12 · Cited by 1
Neuropathology of trisomy 21 mosaicism in a case with early‐onset dementia
Ngo, P. T., Pascual, J. R., Wright, S. T., Williams, C. K., Magaki, S., Yong, W. H., Vinters, H. V., Ringman, J. M., & Head, E. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14394 · Cited by 1
Self-citationContributions of the neurological examination to the diagnosis of dementia in Down syndrome
Lott, I. T., Rosas, H. D., Lai, F., & Zaman, S. H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818845-3.00003-7 · Cited by 1
Self-citationDiffuse cerebral microbleeds in a young adult with Down syndrome
Sohn, E. H., & Lee, A. Y. (2021) · Annals of Clinical Neurophysiology · doi:10.14253/acn.2021.23.1.65
Esteban, O., Marcuello, C., Martínez, M., Lavilla, L., Marco, S., & Ascaso, F. J. (2021) · Archivos de la Sociedad Española de Oftalmología · doi:10.1016/j.oftal.2021.01.011
Mortality and morbidity of infants with trisomy 21, weighing 1500 grams or less, in Japan
Kawasaki, H., Yamada, T., Takahashi, Y., Nakayama, T., Wada, T., Kosugi, S., Kusuda, S., Fujimura, M., Nakamura, H., Nishida, H., et al. (2022) · Journal of Human Genetics · doi:10.1038/s10038-022-01061-w
Alzheimer disease and neuroinflammation in Down syndrome
Ganguly, B. B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90456-8.00014-4
León-Paz-de-Rodríguez, G. E., Rodríguez-León, E., & Iñiguez-Palomares, R. A. (2024) · ACS Omega · doi:10.1021/acsomega.3c07379
Aging and dementia in Down syndrome
Ali, S., Pelt, K. L. V., Head, E., Harp, J. P., Glueck, A. C., & Schmitt, F. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19041-4.00037-6
Self-citationYang, Z., & Lei, P. (2024) · Scientia Sinica Vitae · doi:10.1360/ssv-2024-0201
Familial Alzheimer’s disease and Down syndrome
Castellani, R. J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-99651-8.00022-3
Lipoprotein(a) levels in Down syndrome: A conundrum
Rosas, H. D., Lai, F., & Mercaldo, N. D. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70338
Study of brain perfusion in adults with Down syndrome along the Alzheimer's disease continuum
Franquesa‐Mullerat, M., Morcillo-Nieto, A. O., Arriola‐Infante, J. E., Zsadanyi, S. E., Vaqué‐Alcázar, L., Aranha, M. R., Arranz, J., Rodríguez‐Baz, Í., Maure‐Blesa, L., Videla, L., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70581
Ghosh, U., Tse, E., Yang, H., Shi, M., Caro, C. D., Wang, F., Merz, G. E., Prusiner, S. B., Southworth, D. R., & Condello, C. (2024) · Figshare · doi:10.6084/m9.figshare.26732911
Węgiel, J., Flory, M. J., Kuchna, I., Nowicki, K., Wegiel, J., Ma, S. Y., Zhong, N., Wierzba‐Bobrowicz, T., de Leon, M., Lai, F., et al. (2022) · Figshare · doi:10.6084/m9.figshare.17870374
Ghosh, U., Tse, E., Yang, H., Shi, M., Caro, C. D., Wang, F., Merz, G. E., Prusiner, S. B., Southworth, D. R., & Condello, C. (2024) · Figshare · doi:10.6084/m9.figshare.26732908
Metadata
- Authors
- Head, E., Phelan, M. J., Doran, E., Kim, R. C., Poon, W. W., Schmitt, F. A., & Lott, I. T.
- Affiliations
- University of Kentucky (US)
- University of California, Irvine (US)
- Corresponding author
- Head, Elizabeth
- Venue
- Acta Neuropathologica Communications
- Published
- 2017-12
- Volume
- 5
- Issue
- 1
- Pages
- 93-93
- ISSN
- 2051-5960 (ISSN-L)
- PMC
- PMC5709935
- OpenAlex
- W2771929031
- Cited by
- 105
- References
- 61
- Citations by year
- 2026: 9 · 2025: 22 · 2024: 18 · 2023: 9 · 2022: 12 · 2021: 15 · 2020: 8 · 2019: 8 · 2018: 4
- FWCI
- 5.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Acta Neuropathologica Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- UKnowledge (University of Kentucky) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institute on Aging (P50AG16573, R01AG21912)
- National Institute of Child Health and Human Development (R01HD065160, R01HD064993)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Down syndrome, Alzheimer's disease, cerebral amyloid angiopathy, cerebrovascular pathology, atherosclerosis, arteriolosclerosis, amyloid-beta deposition, vascular risk factors, postmortem brain
- MeSH terms
- Age Factors, Aged, Aged, 80 and over, Alzheimer Disease, Down Syndrome, Female, Humans, Male, Middle Aged, Probability, Cohort Studies, Cerebral Amyloid Angiopathy, Atherosclerosis, Arteriolosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review